NSNienke Soeters

Nienke Soeters

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nienke Soeters has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Nayyirih G. Tahzib

    Zonnestraal Eye Hospital Amersfoort, Amersfoort, The Netherlands

    6 shared publications
  • Allegonda Van der Lelij

    From the Utrecht Cornea Research Group (Soeters, van Bussel, van der Valk, Van der Lelij), Department of Ophthalmology, University Medical Center Utrecht, Utrecht, and Zonnestraal Eye Hospital (Tahzib), Amersfoort, the Netherlands

    3 shared publications
  • Rikkert van der Valk

    3 shared publications
  • Erik van Bussel

    From the Utrecht Cornea Research Group (Soeters, van Bussel, van der Valk, Van der Lelij), Department of Ophthalmology, University Medical Center Utrecht, Utrecht, and Zonnestraal Eye Hospital (Tahzib), Amersfoort, the Netherlands

    1 shared publication
  • Esther Simone Visser

    Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands; Visser Contact Lens Practice, Nijmegen, The Netherlands

    1 shared publication
  • Laura Bakker

    Utrecht Cornea Research Group Department of Ophthalmology University Medical Center Utrecht Utrecht The Netherlands

    1 shared publication

Latest Publications

  • Scleral lens influence on corneal curvature and pachymetry in keratoconus patients

    by Nienke Soeters, Esther Simone Visser, Saskia M. Imhof, Nayyirih G. Tahzib


  • Standard and Hypoosmolar Corneal Cross‐linking in Various Pachymetry Groups

    by Nienke Soeters, Nayyirih G. Tahzib

    Purpose: To investigate the influence of corneal thickness on the outcome of corneal cross‐linking (CXL) for progressive keratoconus. Methods: In this cohort study, 72 unilateral eyes were treated by CXL and divided into three groups according to central corneal thickness (CCT) measured by ultrasound pachymetry after 30‐minute riboflavin. Group 1 (CCT 460 μm) underwent standard CXL. Visual acuity, refraction, topography, ultrasound and optical pachymetry, intraocular pressure, endothelial cell count, and complications were evaluated 1 year post‐CXL. Results: Ultrasound CCT after riboflavin instillation decreased significantly in groups 1 and 2 (−57 ± 44 μm and −39 ± 23 μm, respectively) and increased in group 3 (+15 ± 37 μm). One year post‐CXL, maximal keratometry decreased significantly in group 2. Keratoconus progression was halted in 92% (group 1), 97% (group 2), and 86% (group 3). Optical pachymetry decreased significantly in all groups. Corrected distance visual acuity improved significantly in groups 1 and 3. No significant difference was found in visual acuity, keratometry, optical pachymetry, or endothelial cell density change between groups. Complication rates were comparable between the groups; there was no significant difference in CXL failure (p = 0.687) or corrected distance visual acuity loss (p = 0.617). Conclusions: During CXL, corneas with CCT less than or equal to 460 μm seem to dehydrate faster than corneas with CCT greater than 460 μm. Both standard and hypoosmolar CXL are safe and effective treatments, with comparable amounts of stabilization after 1 year.


  • Corneal Cross-linking for Treatment of Progressive Keratoconus in Various Age Groups

    by Nienke Soeters, Rikkert van der Valk, Nayyirih G. Tahzib

    PURPOSE: To compare the effect of corneal cross-linking (CXL) for keratoconus in various age groups and to investigate the influence of the topographic cone location on the outcome of CXL. METHODS: This cohort study included 95 patients (119 eyes) diagnosed as having progressive keratoconus who underwent epithelium-off standard protocol CXL from January 2010 through May 2012. For statistical analysis, patients were divided into three age groups: pediatric patients (< 18 years), adolescent patients (18 to 26 years), and adults (> 26 years). Visual acuity and refraction, topography, intraocular pressure, and endothelial cell counts were recorded preoperatively and postoperatively. RESULTS: Topographic cones were located more centrally in pediatric corneas (0.85 ± 0.66 mm) compared to adolescent corneas (1.49 ± 0.76 mm, P = .002) and adult corneas (1.86 ± 0.99 mm, P < .001). Pediatric corneas flattened 1 year after CXL by a mean of 1.8 diopters (D), compared to 1.1 D in the other age groups. Central cones (0 to 1 mm) were steeper (62.3 ± 8.3 D) before treatment than peripheral cones (3 to 4 mm) (55.9 ± 8.9 D). One year after CXL, corrected distance visual acuity improved in all age groups, with the highest improvement in pediatric eyes (−0.23 ± 0.40 logMAR, P = .044). CONCLUSIONS: Before CXL, cones of pediatric keratoconic corneas were located more centrally than in the two older age groups. After CXL, pediatric corneas showed more corneal flattening and more corrected distance visual acuity improvement. Pediatric CXL was equally safe compared to adolescent and adult CXL. [ J Refract Surg. 2014;30(7):454–460.]


  • Effect of the eyelid speculum on pachymetry during corneal collagen crosslinking in keratoconus patients

    by Nienke Soeters, Erik van Bussel, Rikkert van der Valk, Allegonda Van der Lelij, Nayyirih G. Tahzib

    To compare central corneal thickness (CCT) with and without using an eyelid speculum during corneal collagen crosslinking (CXL). University Medical Center Utrecht, Utrecht, the Netherlands. Prospective nonrandomized comparative study. Eyes with progressive keratoconus were treated by CXL and consecutively divided into 2 groups. In Group A, an eyelid speculum remained in place throughout the entire CXL procedure. In Group B, the eyelids remained closed during the 30-minute riboflavin instillation. Intraoperative ultrasound pachymetry measurements were performed at different timepoints. The visual acuity, refraction, keratometry, pachymetry, and endothelium were evaluated 6 months after CXL. The main outcome measures were intraoperative CCT measurements and the clinical CXL effect after 6 months. Fifty-two eyes (50 patients) were treated. After riboflavin instillation, a statistically significant difference in CCT reduction was found between the 2 groups (P<.001), with a mean CCT decrease of 62 μm±53 (SD) (13%±11%) in Group A and 11±35 μm (2%±8%) in Group B. No statistically significant between-group differences were found after epithelial removal or ultraviolet-A (UVA) irradiation. Six months after CXL, no statistically significant between-group difference was found in the visual acuity, refraction, keratometry, pachymetry, or endothelium. Avoidance of an eyelid speculum during riboflavin instillation resulted in less CCT reduction during CXL. This finding could increase the chance of attaining the required pachymetry safety margin for applying UVA and thus decrease the chance of premature CXL treatment termination. No author has a financial or proprietary interest in any material or method mentioned.


  • Two Cases of Keratoconus Diagnosed After Pregnancy

    by Nienke Soeters, Nayyirih G. Tahzib, Laura Bakker, Allegonda Van der Lelij

    Purpose.: This case report aims to demonstrate that pregnancy‐induced biomechanical corneal changes in combination with risk factors for ectasia can develop into (the exacerbation of) keratoconus. Case Report.: We describe two women who were clinically diagnosed with keratoconus after their second pregnancy. Both women were myopic and had a history of allergies and contact lens wear. It is unclear whether these two women had a newly diagnosed keratoconus that developed during pregnancy or had experienced an exacerbation of an unrecognized, subclinical keratoconus. Conclusions.: Nowadays, documented progression of keratoconus can be treated by corneal crosslinking to stabilize the weakened cornea. Therefore, it is important to understand the effects of hormonal changes in (keratoconic) eyes during pregnancy and to include topographic imaging in unexplained visual deterioration in young individuals, especially during or after a pregnancy.


  • Corneal Crosslinking for Progressive Keratoconus in Four Children

    by Nienke Soeters, Allegonda Van der Lelij, Rikkert van der Valk, Nayyirih G. Tahzib

    The authors describe four children with progressive keratoconus treated by corneal crosslinking (CXL). The current CXL guidelines recommend treatment of patients 18 years and older. Nevertheless, keratoconus can rapidly progress in young teenagers. CXL could be a safe procedure to prevent a keratoplasty at a young age.